Antibody Therapeutics Patients First!

공지사항

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are attending BIO 2018.
  • 글쓴이 관리자
  • 작성일 2018-08-06 13:24:31
  • 조회수 180

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are attending BIO 2018 (http://convention.bio.org/2018/).

 

 

For investors attending the BIO 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management 

at sungwoo.kim@pharmabcine.com.

목록





이전글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...